Hepatosplenic candidiasis in patients with acute leukemia: Incidence and prognostic implications

Clinical Infectious Diseases

Volumn 24, Issue 3, 1997, Pages 375-380

  Anttila, Veli Jukka ^a   Elonen, Erkki ^b   Nordling, Stig ^b   Sivonen, Aulikki ^b   Ruutu, Tapani ^b   Ruutu, Petri ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANDIDIASIS; FEMALE; HEPATOSPLENOMEGALY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031028897     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.3.375     Document Type: Article

References (16)

1. DeGregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA. Fungal infections in patients with acute leukemia. Am J Med 1982;73:543-8.
2. Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988;108:88-100.
3. Bodey G, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109.
4. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 1995;21:361-9.
5. Haron E, Feld R, Tuffnell P, Patterson B, Hasselback R, Matlow A. Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med 1987;83:17-26.
6. Anttila V-J, Ruutu P, Bondestam S, et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 1994;18:979-81.
7. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984;77(suppl 4D):20-7.
8. Guiot HFL, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:525-32.
9. Loeliger A, van Leeuwen M, Rozenberg-Arska M, Dekker AW. Hepatosplenic candidiasis, a fatal disease? Infection 1992;20:336-38.
10. Tashjian LS, Abramson JS, Peacock JE Jr. Focal hepatic candidiasis: a distinct clinical variant of candidiasis in immunocompromised patients. Rev Infect Dis 1984;6:689-703.
11. Palva IP, Almqvist A, Elonen E, et al. Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemia. Eur J Haematol 1991;47:229-33.
12. Elonen E, Almqvist A, Hanninen A, et al. Intensive chemotherapy of adult AML: a randomized trial between 4 and 8 cycles [abstract no 1297]. Blood 1993;82(10)(suppl 1):328a.
13. Lister TA, Whitehouse JMA, Beard MEJ, et al. Combination chemotherapy for acute lymphoblastic leukaemia in adults. Br Med J 1978;1:199-203.
14. Finnish Leukaemia Group. Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Eur J Haematol 1992;48:75-82.
15. Elonen E, Almqvist A, Hänninen A, et al. Intensive cyclical chemotherapy in the treatment of adults with acute lymphatic leukaemia [abstract no 244]. In: Proceedings of the 24th International Congress of Haematology. London: International Society of Haematology, 1992:62.
16. Anttila V-J, Lamminen EA, Bondestam S, et al. Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia. Eur J Haematol 1996;56:82-7.